BEYOND Follow-up: Betaferon®/Betaseron® Efficacy Yielding Outcomes of a New Dose
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The BEYOND Follow-Up study will give patients who participated in the preceding BEYOND study
the opportunity to continue treatment with the 500µg dose of interferon beta (IFNB) 1b and
will further investigate the safety and tolerability profile of interferon beta 1b 500µg
during longer-term treatment.